Welcome to our dedicated page for Reliance Global Group SEC filings (Ticker: RELIW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Acquisitions, warrant conversions, and AI-driven insurance platforms make Reliance Global Group’s disclosures dense. If you’ve ever typed “Reliance Global Group SEC filings explained simply” or wondered how to track “Reliance Global Group insider trading Form 4 transactions,” you know the challenge: combing through hundreds of pages to learn how each newly purchased agency affects commission revenue and goodwill.
Stock Titan turns that problem into a two-minute read. Our AI-powered summaries break down every Reliance Global Group annual report 10-K simplified for segment revenue shifts, flag any Reliance Global Group 8-K material events explained, and deliver point-by-point Reliance Global Group quarterly earnings report 10-Q filing insight. Real-time alerts push “Reliance Global Group Form 4 insider transactions real-time” to your dashboard, while expert notes connect Reliance Global Group proxy statement executive compensation details to dilution risk. You’ll also find:
- Instant highlights of Reliance Global Group executive stock transactions Form 4
- Side-by-side Reliance Global Group earnings report filing analysis across quarters
- Clear callouts when acquisition accounting changes future cash flows
Whether you’re understanding Reliance Global Group SEC documents with AI for the first time or benchmarking industry multiples, our platform covers every filing type as soon as it hits EDGAR. Skip the PDF scroll—focus on what rising commission margins, technology spend, and warrant redemptions mean to valuation. All filings, all the time, already decoded.
Reliance Global Group has entered an At The Market (ATM) sales agreement with H.C. Wainwright to sell up to $2,026,453 of common stock, with Wainwright earning a 3.0% commission. The prospectus uses an assumed offering price of $1.02 per share (closing price on August 6, 2025) and also reports a last reported sale price of $1.05 on August 11, 2025.
Recent material actions include a Series J private placement (June 18, 2025) providing pre-funded warrants to purchase 1,488,096 shares at $0.001 and Series J warrants to purchase 2,976,192 shares at $1.43, and issuance of a placement-agent warrant for 104,167 shares at $2.10. The Company closed the sale of Fortman Insurance for $5,000,000 (effective July 1, 2025), classified Fortman assets held for sale totaling $2,299,767 with related liabilities $289,732, and expects an estimated $2.99 million gain in Q3 2025. Proceeds funded Oak Street debt pre-payments of $4,997,292, leaving a net Oak Street balance of $5,374,461.
The balance sheet showed a net tangible book value of $(7,684,198) (approximately $(2.48) per share) as of June 30, 2025; after pro forma adjustments the as-adjusted figure would be about $(0.90) per share, implying an immediate dilution of $1.92 per share for new investors. Outstanding potential dilution includes 3,866,040 warrants and 1,873,259 unvested equity awards. The prospectus highlights standard offering and market risks, including volatility, dilution, and penny stock considerations.